Brown Advisory Securities’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Brown Advisory Securities’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-6,685	Closed	-$488K	–	370
2018 Q4	$488K	Sell	6,685 -2,735	-29%	-$220K	0.09%	192
2018 Q3	$902K	Buy	9,420 +1,285	+16%	+$125K	0.14%	143
2018 Q2	$775K	Buy	8,135 +3,530	+77%	+$324K	0.13%	158
2018 Q1	$404K	Buy	4,605 +145	+3%	+$13.2K	0.08%	242
2017 Q4	$380K	Hold	4,460	–	–	0.07%	245
2017 Q3	$386K	Hold	4,460	–	–	0.08%	226
2017 Q2	$345K	Hold	4,460	–	–	0.08%	229
2017 Q1	$309K	Hold	4,460	–	–	0.08%	233
2016 Q4	$264K	Buy	+4,460	New	+$275K	0.07%	249
2015 Q2	–	Sell	-3,294	Closed	-$247K	–	340
2015 Q1	$247K	Hold	3,294	–	–	0.09%	235
2014 Q4	$206K	Buy	+3,294	New	+$188K	0.07%	246

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Brown Advisory Securities's XBI Position: Q1 2019 in Review

Brown Advisory Securities sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2019, closing a stake of 6,685 shares — an estimated $488K sold.

Brown Advisory Securities first reported a position in XBI in Q4 2014 and held it in 11 quarters. The position peaked at $902K in Q3 2018. 451 funds tracked by Wall St. Rank hold XBI as of Q1 2019.

Brown Advisory Securities reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2019 after selling out during the quarter.
Brown Advisory Securities sold 6,685 State Street SPDR S&P Biotech ETF shares in Q1 2019, an estimated $488K.
Brown Advisory Securities first reported a position in State Street SPDR S&P Biotech ETF in Q4 2014 and held it in 11 quarters.
Brown Advisory Securities's State Street SPDR S&P Biotech ETF position peaked at $902K in Q3 2018.
451 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2019.

Based on Brown Advisory Securities's 13F filing for Q1 2019, filed 14 May 2019.